ArticleNature reviews. Clinical oncology2019
Assembling the brain trust: the multidisciplinary imperative in neuro-oncology.
Abstract readLetterComment
In one paragraph
Article in Nature reviews. Clinical oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies.Molecular oncology · 2022Review
- Reply to 'Assembling the brain trust: the multidisciplinary imperative in neuro-oncology'.Nature reviews. Clinical oncology · 2019Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
51 authors.
Ethan B LudmirDivision of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Anita MahajanDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Verity AhernSydney West Radiation Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia.
Thankamma AjithkumarDepartment of Oncology, Cambridge University Hospitals, Cambridge, UK.
Claire AlapetiteDepartment of Radiation Oncology, Institut Curie, Paris and Orsay, France.
Valérie Bernier-ChastagnerOncology Radiotherapy Institut de Cancérologie de Lorraine, Vandoeuvre les Nancy, France.
Ranjit S BindraDepartment of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT, USA.
Andrew J BishopDivision of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Stephanie BolleDepartment of Radiation Oncology, Gustave Roussy, Villejuif, France.
Paul D BrownDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Christian CarrieDepartment of Radiation Oncology, Centre Léon Bérard, Lyon, France.
Anthony J ChalmersInstitute of Cancer Sciences, University of Glasgow, Glasgow, UK.ORCID http://orcid.org/0000-0002-1746-7278
Eric L ChangDepartment of Radiation Oncology, Keck School of Medicine of USC, Los Angeles, CA, USA.
Caroline ChungDivision of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Karin DieckmannDepartment of Radiation Oncology, Universität Klinik für Strahlentherapie und Strahlenbiologie, Vienna, Austria.
Natia EsiashviliDepartment of Radiation Oncology, Emory University Winship Cancer Institute, Atlanta, GA, USA.
Lorenza GandolaPediatric Radiotherapy Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Amol J GhiaDivision of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Vinai GondiNorthwestern University Feinberg School of Medicine, Chicago, IL, USA.
David R GrosshansDivision of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Semi B HarrabiDepartment of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.
Gail HoranDepartment of Oncology, Cambridge University Hospitals, Cambridge, UK.
Danny J IndelicatoDepartment of Radiation Oncology, University of Florida College of Medicine, Jacksonville, FL, USA.
Rakesh JalaliDepartment of Radiation Oncology, Apollo Proton Cancer Centre, Chennai, Tamil Nadu, India.
Geert O JanssensDepartment of Radiation Oncology, University Medical Center Utrecht, Utrecht, Netherlands.
Mechthild KrauseDepartment of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Nadia N LaackDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Normand LaperriereDepartment of Radiation Oncology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Anne LaprieDepartment of Radiation Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France.
Jing LiDivision of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Karen J MarcusDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Susan L McGovernDivision of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Thomas E MerchantDepartment of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Kenneth W MerrellDepartment of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Laetitia PadovaniDepartment of Radiation Oncology, Assistance Publique Hôpitaux de Marseille, Marseille, France.
Jeannette ParkesDepartment of Radiation Oncology, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa.
Arnold C PaulinoDivision of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Rudolf SchwarzDepartment of Radiation Oncology, Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Helen A ShihDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
Luis SouhamiDepartment of Radiation Oncology, McGill University Health Centre, Cedars Cancer Centre, Montréal, Quebec, Canada.
Erik P SulmanDepartment of Radiation Oncology, New York University Langone School of Medicine, New York, NY, USA.
Roger E TaylorCollege of Medicine, Swansea University, Swansea, UK.
Nicola ThorpDepartment of Oncology, The Clatterbridge Cancer Centre, Liverpool, UK.
Beate TimmermannDepartment of Particle Therapy, University Hospital Essen, West German Proton Therapy Centre Essen, West German Cancer Center, German Cancer Consortium, Essen, Germany.
Greg WheelerDepartment of Radiation Oncology and Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Suzanne L WoldenDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Kristina D WoodhouseDivision of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Debra N YeboaDivision of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Torunn I YockDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
Rolf-Dieter KortmannDepartment of Radiation Oncology, University of Leipzig, Leipzig, Germany.
Mary Frances McAleerDivision of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mfmcalee@mdanderson.org.
Funding
Cancer Research UK 20546
Abstract
PubMed holds no abstract for this paper.
Indexed as
Brain NeoplasmsBrainHumans
Identifiers
PMID
31150024What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.